A share price of Edgewise Therapeutics Inc [EWTX] is currently trading at $17.05, up 5.44%. An important factor to consider is whether the stock is rising or falling in short-term value. The EWTX shares have gain 13.06% over the last week, with a monthly amount drifted -6.52%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on March 07, 2024, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $48. On August 25, 2022, downgrade downgraded it’s rating to Sell but maintained its price target of $5 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $31 on April 13, 2022. Goldman initiated its recommendation with a Neutral and recommended $11 as its price target on January 28, 2022.
Edgewise Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $5.12 and $20.69. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $17.05 at the most recent close of the market.
Analyzing the EWTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.31 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.34 points at the first support level, and at 15.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.68, and for the 2nd resistance point, it is at 18.32.
Edgewise Therapeutics Inc [EWTX] reported earnings per share of -$0.47 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.43/share, meaning a difference of -$0.04 and a surprise factor of -9.30%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.41 per share as compared to estimates of -$0.4 per share, a difference of -$0.01 representing a surprise of -2.50%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Edgewise Therapeutics Inc [NASDAQ:EWTX] is 19.50. On the other hand, the Quick Ratio is 19.50, and the Cash Ratio is 5.13.
Transactions by insiders
Recent insider trading involved MOORE JOHN R, General Counsel, that happened on Feb 09 ’24 when 8029.0 shares were sold. Chief Business Officer, Derakhshan Behrad completed a deal on Feb 09 ’24 to sell 4800.0 shares. Meanwhile, Chief Business Officer Derakhshan Behrad sold 4600.0 shares on Feb 08 ’24.
